Presentation is loading. Please wait.

Presentation is loading. Please wait.

Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with β2-adrenergic agonists  Elena Goleva, PhD, Annegret.

Published byElena Romero Pinto Modified over 5 years ago

Similar presentations

Presentation on theme: "Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with β2-adrenergic agonists  Elena Goleva, PhD, Annegret."— Presentation transcript:

1 Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with β2-adrenergic agonists  Elena Goleva, PhD, Annegret Dunlap, BS, Donald Y.M. Leung, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 114, Issue 1, Pages (July 2004) DOI: /j.jaci

2 Fig 1 PHA-induced proliferation of PBMCs from the healthy control group (A; n=6) or the allergic asthmatic group (B; n=5) in the presence of low concentrations of FP in combination with salmeterol. The data are presented as the percentages of proliferation compared with FP alone (defined as 100%). ∗P < .05, ∗∗P < .01 compared with FP only. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )

3 Fig 2 Salmeterol (10−7 mol/L) combination with suboptimal concentration of FP (10−12 mol/L) enhances GCR nuclear translocation in freshly isolated human PBMCs from healthy control subjects (D) but not from allergic asthmatic patients (C; 630×; blue, DAPI-nuclear staining; red, cy3-GCR). GCR localization in PBMCs from healthy donors before (A) or after (B) treatment with a suboptimal concentration of 10−12 mol/L FP (1 hour at 37°C) is shown as well. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )

4 Fig 3 Inhibition of PHA-induced IFN-γ and TNF-α production with a suboptimal concentration of FP (10−12 mol/L) in combination with salmeterol in PHA-stimulated supernatants from the healthy control group (A and C) or the allergic asthmatic group (B and D). ∗P < .05, ∗∗P < .01 compared with PHA only. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )

5 Fig 4 A, PHA-induced proliferation of PBMCs from allergic asthmatic patients in the presence of low concentrations of FP in combination with salmeterol and the PDE4 inhibitor rolipram. The data are presented as the percentages of proliferation compared with PHA alone (n=5). ∗P < .05 compared with FP only. B, Inhibition of IL-13 mRNA production by PBMCs from allergic asthmatic patients in the presence of FP-salmeterol-rolipram combination (n=7). Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )

6 Fig 4 A, PHA-induced proliferation of PBMCs from allergic asthmatic patients in the presence of low concentrations of FP in combination with salmeterol and the PDE4 inhibitor rolipram. The data are presented as the percentages of proliferation compared with PHA alone (n=5). ∗P < .05 compared with FP only. B, Inhibition of IL-13 mRNA production by PBMCs from allergic asthmatic patients in the presence of FP-salmeterol-rolipram combination (n=7). Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )

Download ppt "Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with β2-adrenergic agonists  Elena Goleva, PhD, Annegret."

Similar presentations

Maria B. Sukkar, PhD, Shaoping Xie, PhD, Nadia M

Maria B. Sukkar, PhD, Shaoping Xie, PhD, Nadia M
Kiyoshi Yamazaki, MD, Joseph A. Murray, MD, Hirohito Kita, MD 

Kiyoshi Yamazaki, MD, Joseph A. Murray, MD, Hirohito Kita, MD 
Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD  Rubaiyat Haque, MBBS,

Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD  Rubaiyat Haque, MBBS,
Food protein–induced enterocolitis syndromes with and without bloody stool have distinct clinicopathologic features  Hideaki Morita, MD, PhD, Hiroko Suzuki,

Food protein–induced enterocolitis syndromes with and without bloody stool have distinct clinicopathologic features  Hideaki Morita, MD, PhD, Hiroko Suzuki,
Increased phenotypic differentiation and reduced corticosteroid sensitivity of fibrocytes in severe asthma  Chun-Yu Lo, MD, Charalambos Michaeloudes,

Increased phenotypic differentiation and reduced corticosteroid sensitivity of fibrocytes in severe asthma  Chun-Yu Lo, MD, Charalambos Michaeloudes,
Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 

Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 
The effects of upper respiratory infection on T-cell proliferation and steroid sensitivity of asthmatics  Elcio O. Vianna, MD, PhD, Jay Westcott, PhD,

The effects of upper respiratory infection on T-cell proliferation and steroid sensitivity of asthmatics  Elcio O. Vianna, MD, PhD, Jay Westcott, PhD,
Cell-to-cell contact between activated CD4+ T lymphocytes and unprimed monocytes interferes with a TH1 response  Miriam Wittmann, MD, Mareike Alter, Tanja.

Cell-to-cell contact between activated CD4+ T lymphocytes and unprimed monocytes interferes with a TH1 response  Miriam Wittmann, MD, Mareike Alter, Tanja.
Tissue factor–bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in vitro and in vivo  Jin-Ah Park, PhD, Asma S.

Tissue factor–bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in vitro and in vivo  Jin-Ah Park, PhD, Asma S.
Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use  Daniel A. Searing, MD, Yong Zhang, PhD, James.

Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use  Daniel A. Searing, MD, Yong Zhang, PhD, James.
Airway microbiome and responses to corticosteroids in corticosteroid-resistant asthma patients treated with acid suppression medications  Elena Goleva,

Airway microbiome and responses to corticosteroids in corticosteroid-resistant asthma patients treated with acid suppression medications  Elena Goleva,
Christine M. Braun, BA, Shau-Ku Huang, PhD, Gregory G

Christine M. Braun, BA, Shau-Ku Huang, PhD, Gregory G
Akos Heinemann, MD, Gunter J. Sturm, MD, Martina Ofner, BSc, Eva M

Akos Heinemann, MD, Gunter J. Sturm, MD, Martina Ofner, BSc, Eva M
Elena Goleva, PhD, Leisa P. Jackson, BS, Melanie Gleason, PA, Donald Y

Elena Goleva, PhD, Leisa P. Jackson, BS, Melanie Gleason, PA, Donald Y
Atopic dermatitis: Age and race do matter!

Atopic dermatitis: Age and race do matter!
Human B cells promote T-cell plasticity to optimize antibody response by inducing coexpression of TH1/TFH signatures  Jelle de Wit, PhD, Tineke Jorritsma,

Human B cells promote T-cell plasticity to optimize antibody response by inducing coexpression of TH1/TFH signatures  Jelle de Wit, PhD, Tineke Jorritsma,
Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes  Naoko Kanda, MD, PhD, Hiroshi Mitsui, MD, PhD, Shinichi.

Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes  Naoko Kanda, MD, PhD, Hiroshi Mitsui, MD, PhD, Shinichi.
IL-10 disrupts the Brd4-docking sites to inhibit LPS-induced CXCL8 and TNF-α expression in monocytes: Implications for chronic obstructive pulmonary disease 

IL-10 disrupts the Brd4-docking sites to inhibit LPS-induced CXCL8 and TNF-α expression in monocytes: Implications for chronic obstructive pulmonary disease 
Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum  Lianghua Bin, MD, PhD, Michael G. Edwards,

Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum  Lianghua Bin, MD, PhD, Michael G. Edwards,
Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL- 5 and IL-5 receptor levels  Miguel L. Stein, MD, Joyce M. Villanueva,

Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL- 5 and IL-5 receptor levels  Miguel L. Stein, MD, Joyce M. Villanueva,

Similar presentations

Ads by Google